Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Botulinum neurotoxin type A injections reduce spasticity in mild to moderate hereditary spastic paraplegia— Report of 19 cases

Identifieur interne : 001A91 ( Istex/Curation ); précédent : 001A90; suivant : 001A92

Botulinum neurotoxin type A injections reduce spasticity in mild to moderate hereditary spastic paraplegia— Report of 19 cases

Auteurs : Martin J. Hecht [Allemagne] ; Henning Stolze [Allemagne] ; Matthias Auf Dem Brinke [Allemagne] ; Ralf Giess [Allemagne] ; Thoams Treig [Allemagne] ; Martin Winterholler [Allemagne] ; Jörg Wissel [Allemagne]

Source :

RBID : ISTEX:F81B4DBBD9C958C89334DDEEF27F05A7B3CA503F

English descriptors

Abstract

Hereditary spastic paraplegia (HSP) is characterized by lower extremity spasticity. Symptomatic therapy generally includes physical therapy and oral antispastic agents, in selected cases intrathecal baclofen. Because of the positive results in other treatments of spasticity, the use of botulinum neurotoxin type A (BoNT‐A) might also be considered for patients with HSP. We report the effect of BoNT‐A injections in 19 unselected patients with HSP treated by the members of the German Spasticity Education Group. In 17 patients, the modified Ashworth scale had improved by one point. In one patient, it improved by three points. Most of the patients reported reduction of spasticity. BoNT‐A injections were continued in 11 of 19 patients (57.9%). All of the patients with continued injections had a good or very good global subjective improvement. Patients with less pronounced spasticity and patients with accompanying physical therapy tended to exhibit a better effect. Only four patients reported adverse effects which were increased weakness in three patients and pain in one patient. BoNT‐A injections appear to reduce spasticity effectively and safely, especially in patients with mild to moderate spasticity. The preliminary results of our case series should encourage larger studies of BoNT‐A injections in HSP. © 2007 Movement Disorder Society

Url:
DOI: 10.1002/mds.21809

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:F81B4DBBD9C958C89334DDEEF27F05A7B3CA503F

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Botulinum neurotoxin type A injections reduce spasticity in mild to moderate hereditary spastic paraplegia— Report of 19 cases</title>
<author>
<name sortKey="Hecht, Martin J" sort="Hecht, Martin J" uniqKey="Hecht M" first="Martin J." last="Hecht">Martin J. Hecht</name>
<affiliation wicri:level="1">
<mods:affiliation>Department of Neurology, University of Erlangen‐Nuremberg, Erlangen, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, University of Erlangen‐Nuremberg, Erlangen</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Department of Neurology, BKH Kaufbeuren, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, BKH Kaufbeuren</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Stolze, Henning" sort="Stolze, Henning" uniqKey="Stolze H" first="Henning" last="Stolze">Henning Stolze</name>
<affiliation wicri:level="1">
<mods:affiliation>Department of Neurology, University of Kiel, Kiel, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, University of Kiel, Kiel</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Department of Neurology, Diako Hospital, Flensburg, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, Diako Hospital, Flensburg</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Auf Dem Brinke, Matthias" sort="Auf Dem Brinke, Matthias" uniqKey="Auf Dem Brinke M" first="Matthias" last="Auf Dem Brinke">Matthias Auf Dem Brinke</name>
<affiliation wicri:level="1">
<mods:affiliation>Department of Neurological Rehabilitation, Bad Wildungen, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurological Rehabilitation, Bad Wildungen</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Giess, Ralf" sort="Giess, Ralf" uniqKey="Giess R" first="Ralf" last="Giess">Ralf Giess</name>
<affiliation wicri:level="1">
<mods:affiliation>Department of Neurology, Henriettenstiftung, Hannover, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, Henriettenstiftung, Hannover</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Treig, Thoams" sort="Treig, Thoams" uniqKey="Treig T" first="Thoams" last="Treig">Thoams Treig</name>
<affiliation wicri:level="1">
<mods:affiliation>Neurological Rehabilitation Centre, Ernst‐Moritz‐Arndt University, Greifswald, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Neurological Rehabilitation Centre, Ernst‐Moritz‐Arndt University, Greifswald</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Neurological Rehabilitation Centre, Schwarzwaldkliniken, Bad Krozingen, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Neurological Rehabilitation Centre, Schwarzwaldkliniken, Bad Krozingen</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Winterholler, Martin" sort="Winterholler, Martin" uniqKey="Winterholler M" first="Martin" last="Winterholler">Martin Winterholler</name>
<affiliation wicri:level="1">
<mods:affiliation>Department of Neurology, Rummelsberger Kliniken, Schwarzenbruck, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, Rummelsberger Kliniken, Schwarzenbruck</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Wissel, Jorg" sort="Wissel, Jorg" uniqKey="Wissel J" first="Jörg" last="Wissel">Jörg Wissel</name>
<affiliation wicri:level="1">
<mods:affiliation>Department of Neurological Rehabilitation, Beelitz Heilstätten, Beelitz, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurological Rehabilitation, Beelitz Heilstätten, Beelitz</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F81B4DBBD9C958C89334DDEEF27F05A7B3CA503F</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/mds.21809</idno>
<idno type="url">https://api.istex.fr/document/F81B4DBBD9C958C89334DDEEF27F05A7B3CA503F/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001A91</idno>
<idno type="wicri:Area/Istex/Curation">001A91</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Botulinum neurotoxin type A injections reduce spasticity in mild to moderate hereditary spastic paraplegia— Report of 19 cases</title>
<author>
<name sortKey="Hecht, Martin J" sort="Hecht, Martin J" uniqKey="Hecht M" first="Martin J." last="Hecht">Martin J. Hecht</name>
<affiliation wicri:level="1">
<mods:affiliation>Department of Neurology, University of Erlangen‐Nuremberg, Erlangen, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, University of Erlangen‐Nuremberg, Erlangen</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Department of Neurology, BKH Kaufbeuren, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, BKH Kaufbeuren</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Stolze, Henning" sort="Stolze, Henning" uniqKey="Stolze H" first="Henning" last="Stolze">Henning Stolze</name>
<affiliation wicri:level="1">
<mods:affiliation>Department of Neurology, University of Kiel, Kiel, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, University of Kiel, Kiel</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Department of Neurology, Diako Hospital, Flensburg, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, Diako Hospital, Flensburg</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Auf Dem Brinke, Matthias" sort="Auf Dem Brinke, Matthias" uniqKey="Auf Dem Brinke M" first="Matthias" last="Auf Dem Brinke">Matthias Auf Dem Brinke</name>
<affiliation wicri:level="1">
<mods:affiliation>Department of Neurological Rehabilitation, Bad Wildungen, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurological Rehabilitation, Bad Wildungen</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Giess, Ralf" sort="Giess, Ralf" uniqKey="Giess R" first="Ralf" last="Giess">Ralf Giess</name>
<affiliation wicri:level="1">
<mods:affiliation>Department of Neurology, Henriettenstiftung, Hannover, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, Henriettenstiftung, Hannover</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Treig, Thoams" sort="Treig, Thoams" uniqKey="Treig T" first="Thoams" last="Treig">Thoams Treig</name>
<affiliation wicri:level="1">
<mods:affiliation>Neurological Rehabilitation Centre, Ernst‐Moritz‐Arndt University, Greifswald, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Neurological Rehabilitation Centre, Ernst‐Moritz‐Arndt University, Greifswald</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>Neurological Rehabilitation Centre, Schwarzwaldkliniken, Bad Krozingen, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Neurological Rehabilitation Centre, Schwarzwaldkliniken, Bad Krozingen</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Winterholler, Martin" sort="Winterholler, Martin" uniqKey="Winterholler M" first="Martin" last="Winterholler">Martin Winterholler</name>
<affiliation wicri:level="1">
<mods:affiliation>Department of Neurology, Rummelsberger Kliniken, Schwarzenbruck, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, Rummelsberger Kliniken, Schwarzenbruck</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Wissel, Jorg" sort="Wissel, Jorg" uniqKey="Wissel J" first="Jörg" last="Wissel">Jörg Wissel</name>
<affiliation wicri:level="1">
<mods:affiliation>Department of Neurological Rehabilitation, Beelitz Heilstätten, Beelitz, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurological Rehabilitation, Beelitz Heilstätten, Beelitz</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008-01-30">2008-01-30</date>
<biblScope unit="vol">23</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="228">228</biblScope>
<biblScope unit="page" to="233">233</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">F81B4DBBD9C958C89334DDEEF27F05A7B3CA503F</idno>
<idno type="DOI">10.1002/mds.21809</idno>
<idno type="ArticleID">MDS21809</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>HSP</term>
<term>botulinum toxin A</term>
<term>hereditary spastic paraplegia</term>
<term>spasticity</term>
<term>therapy</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Hereditary spastic paraplegia (HSP) is characterized by lower extremity spasticity. Symptomatic therapy generally includes physical therapy and oral antispastic agents, in selected cases intrathecal baclofen. Because of the positive results in other treatments of spasticity, the use of botulinum neurotoxin type A (BoNT‐A) might also be considered for patients with HSP. We report the effect of BoNT‐A injections in 19 unselected patients with HSP treated by the members of the German Spasticity Education Group. In 17 patients, the modified Ashworth scale had improved by one point. In one patient, it improved by three points. Most of the patients reported reduction of spasticity. BoNT‐A injections were continued in 11 of 19 patients (57.9%). All of the patients with continued injections had a good or very good global subjective improvement. Patients with less pronounced spasticity and patients with accompanying physical therapy tended to exhibit a better effect. Only four patients reported adverse effects which were increased weakness in three patients and pain in one patient. BoNT‐A injections appear to reduce spasticity effectively and safely, especially in patients with mild to moderate spasticity. The preliminary results of our case series should encourage larger studies of BoNT‐A injections in HSP. © 2007 Movement Disorder Society</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A91 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 001A91 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Istex
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:F81B4DBBD9C958C89334DDEEF27F05A7B3CA503F
   |texte=   Botulinum neurotoxin type A injections reduce spasticity in mild to moderate hereditary spastic paraplegia— Report of 19 cases
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024